|
| |
MGI Pharma Pages on BioPortfolio:
MGI Pharma's 5HT3 antagonist, Aloxi (palonosetron), is effective ...
Targeting oncolytic viruses to colorectal tumors, Increasing the anticancer efficacy of docetaxel by ERK inhibitors.
http://www.bioportfolio.com/LeadDiscovery/PubMed-020506.html...
|
BioPortfolio - MGI Pharma - Profile
MGI PHARMA, Inc. is a pharmaceutical company that acquires, develops and markets ... Division of Medical and Scientific Affairs, MGI Pharma, Bloomington ...
http://www.bioportfolio.com/biocorporate/7006-MGI%2525252525...
|
BioPortfolio - MGI Pharma
MGI Pharma - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/7006-MGI_Pharma.htm...
|
BioPortfolio - MGI Pharma dipeptidyl peptidase IV inhibitors
The research group lists collaboration with MGI Pharma Inc in the area of .... Theproducts are the dipeptidyl peptidase (DPP)-IV inhibitors that . ...
http://www.bioportfolio.com/search/MGI_Pharma_dipeptidyl_pep...
|
BioPortfolio - BioPortfolio - MGI Pharma
BioPortfolio - MGI Pharma - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/7006/www.mg...
|
BioPortfolio - AkaRx Inc.
Aquavan, nearing submission, MGI Pharma Inc. decided to add a new drug to ... thrombocytopenia drug from small biotech firm AkaRx Inc. . ...
http://www.bioportfolio.com/search/AkaRx_Inc..html...
|
BioPortfolio - microgen Pharma
The resulting company, MGI Pharma Biologics, is actively pursing the ... https:/ /www.utmb.edu/utmbmagazine/archive/05_Fall/class_note. ...
http://www.bioportfolio.com/search/microgen_Pharma.html...
|
BioPortfolio - heparin from gland pharma,India
Award for proposal, "A Transmural Heparin Delivery System for Prevention of .... .. induced Salivary Gland Hypofunction", Principal Investigator, MGI Pharma, ...
http://www.bioportfolio.com/search/heparin_from_gland_pharma...
|
BioPortfolio - AkaRx.com
MGI Pharma Inc has obtained rights to develop AkaRx Inc's ... US $45 million to AkaRx, but will not be required to make . ...
http://www.bioportfolio.com/search/AkaRx.com.html...
|
The Board of International Biotechnology Trust Plc (“IBT”) today ...
27 Sep 2005 ... Just after our year end, MGI Pharma received an approvable letter from the FDA on Dacogen for a type of leukaemia which bodes well for an ...
http://www.bioportfolio.com/news/International_Biotechnology...
|
Results from other life science and pharmaceutical sites:
Making a Real Difference in the Lives of Patients : MGI PHARMA
MGI PHARMA, INC. and its subsidiaries have become a wholly-owned subsidiary ... access relevent MGI PHARMA content such as product and pipeline information. ...
http://www.guilfordpharm.com/...
|
BioSpace - MGI PHARMA, INC. News, Search Jobs, Events
MGI PHARMA, INC. (MOGN)'s Aloxi(R) Phase 3 Data for Post Operative Nausea and Vomiting (PONV) Presented at the Annual Meeting of the American Society of ...
http://www.biospace.com/company_profile.aspx?CompanyID=2383...
|
DailyMed: About DailyMed
HEXALEN® (altretamine) capsules is a registered trademark of MGI PHARMA, INC. Manufactured by: AAI Development Services. An aaiPharma® Company ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=2784...
|
BioSpace - MGI PHARMA Biologics News, Search Jobs, Events
MGI PHARMA Biologics (Company has closed.) Press releases archived for reference only. Lexington Massachusetts U.S.A.. Phone: n/a Fax: n/a ...
http://www.biospace.com/company_profile.aspx?CompanyId=96312...
|
EISAI TO ACQUIRE MGI PHARMA FOR $41 PER SHARE IN AN ALL CASH ...
10 Dec 2007 ... The acquisition is structured as an all cash tender offer for all outstanding shares of MGI PHARMA common stock ...
http://www.eisai.com/presskits/Press%20Release%20--%20Eisai%...
|
MGI Pharma's 5HT3 antagonist, Aloxi (palonosetron), is effective ...
Targeting oncolytic viruses to colorectal tumors, Increasing the anticancer efficacy of docetaxel by ERK inhibitors.
http://www.bioportfolio.com/LeadDiscovery/PubMed-020506.html...
|
DailyMed: About DailyMed
MGI PHARMA, INC. Distributed and marketed by MGI PHARMA, INC. Bloomington, MN. 55437 under license of Helsinn Healthcare SA, Switzerland. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=5600...
|
EISAI COMPLETES ACQUISITION OF MGI PHARMA
merger, will mail to the remaining former shareholders of MGI PHARMA materials necessary to. exchange their former MGI PHARMA shares for such payment. ...
http://www.eisai.com/presskits/Eisai%20Completes%20Acquisiti...
|
BioSpace - MGI PHARMA, INC. News, Search Jobs, Events
MGI PHARMA, INC. (MOGN) Announces Results from Study Involving the Dual Implantation of Gliadel® Wafer and Radioactive Seeds for Treatment of Recurrent
...
http://www.biospace.com/company_profile.aspx?CompanyId=10019...
|
BioPortfolio - MGI Pharma - Profile
MGI PHARMA, Inc. is a pharmaceutical company that acquires, develops and markets ... Division of Medical and Scientific Affairs, MGI Pharma, Bloomington ...
http://www.bioportfolio.com/biocorporate/7006-MGI%2525252525...
|
|
